WEGO Health throws Ning network users a lifeline with sponsorship

Share this article:
WEGO Health is sponsoring all health networks at social networking platform Ning.com, enabling a million Ning network users to go on posting free of charge as the company phases out its free networks.

The one-year deal will provide Ning Plus service to users of Ning networks like People Living with Sickle Cell, which was started two years ago by WEGO user Ade Adeyokunnu.

“I'm a member of WEGO Health's network of health activists, and it's been a great way to connect with and learn from other people like me who build health communities,” said Adeyokunnu in a release. “I started People Living with Sickle Cell on Ning two years ago to give sickle cell disease patients and caregivers a place to meet and talk about what we're all going through, so I'm really glad they'll be able to continue to grow and thrive on Ning.”

The sponsorship gives Ning networks unlimited membership, full branding controland the ability to create groups, chats and events, along with access to WEGO's community of health activists, the firm said. WEGO will work over the next year “with other industry leaders to fund the expansion and extension of this sponsorship.” Ning recently announced a similar sponsorship by Pearson Publishing of education-focused Ning networks.

“The health networks built on Ning are a powerful example of health activists at work,” said WEGO CEO Jack Barrette, “and we're thrilled to be able to extend our mission through this sponsorship. We look forward to collaborating with health-focused Ning network creators to expand their reach and impact.”

Ning, a potential competitor to Facebook and MySpace that allows users to construct social networks around topics or areas of interest, announced in April amid a sharp downsizing that it was cutting its free networks loose to focus on its paid networks.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.

Five things for Pharma Marketers to Know: Thursday, August 28

Five things for Pharma Marketers to Know: Thursday, ...

Human testing of GSK's Ebola virus starts next week, menopause is a costly healthcare concern, and a small conversation with pharmacists may have a big impact.